Recruiting Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors NCT06625775 Conditions Advanced Breast Cancer, Advanced Lung Cancer, Breast Diseases, +35 more Locations City of Hope Comprehensive Cancer Center — Duarte, California, United States University of California Los Angeles — Los Angeles, California, United States University of California San Diego Moores Cancer Center — San Diego, California, United States UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States View all 40 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study NCT06805812 Conditions Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more Locations Centro di Riferimento Oncologico IRCCS — Aviano, Italy Azienda Socio Sanitaria Territoriale degli Spedali Civili — Brescia, Italy Humanitas Istituto Clinico Catanese — Catania, Italy ASST Lariana - Ospedale Sant'Anna — Como, Italy View all 24 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer NCT04796623 Conditions HR-positive, HER2-negative Advanced Breast Cancer Locations The Fifth Medical Center of PLA General Hospital — Beijing, Beijing Municipality, China Chongqing University Cancer Hospital — Chongqing, Chongqing Municipality, China Gansu Provincial Hostipal — Lanzhou, Gansu, China Guangdong General Hospital — Guangzhou, Guangdong, China View all 17 locations View more locations Show fewer locations Loading locations... View Trial Details
